Omeicos Therapeutics GmbH

https://www.omeicos.com

OMEICOS Therapeutics is a spin-off company from the Max Delbrueck Center for Molecular Medicine (MDC) in Berlin. The company has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat inflammatory, cardiovascular and other diseases. Epoxyeicosanoids, as a newly described class of bioactive lipid mediators, activate cell type-specific endogenous pathways that promote organ and tissue protection. OMEICOS’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. OMEICOS’ technology is based on ground-breaking scientific results in the field of omega-3 fatty acid metabolism and physiology obtained by the companies’ founders, Dr. Wolf-Hagen Schunck, Prof. John. R. Falck, Prof. Dominik Mueller and Dr. Robert Fischer. The companies’ research activities are supported by a grant from the German Ministry of Education and Research (BMBF). *

	Start	2013-07-05 splitoff
	Group	Omeicos (Group)
	Predecessor	Max Delbrück Center for Molecular Medicine (MDC)
	Industry	cardiovascular drug
	Industry 2	ophthalmic
	Person	Fischer, Robert (Omeicos Therapeutics GmbH 201312 Managing Director (CSO))
	Person 2	Gebauer, Alexander (Secarna 202102– Managing Director (CEO) before Omeicos + Sun Pharma + Ranbaxy + Merz Pharma)

	Region	Berlin
	Country	Germany
	Street	10 Robert-Rössle-Str. Campus Berlin-Buch
	City	13125 Berlin
	Tel	+49-30-9489-4810
		Address record changed: 2024-01-05

Basic data	Employees	A: 1 to 10 (2014-11-01)

		* Document for »About Section«: Omeicos Therapeutics GmbH. (4/27/18). "Press Release: Alexander Gebauer Joins Executive Board of Omeicos Therapeutics and Named CEO and Chairman of Omeicos Ophthalmics". Berlin & Boston, MA.

		Record changed: 2023-12-30

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x200px

More documents for Omeicos (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)